Is compounded semaglutide the same molecule as Ozempic or Wegovy?

Compounded semaglutide uses the same active pharmaceutical ingredient. The differences are formulation, base (acetate vs sodium), excipients, and pharmacy source. Clinics should disclose this clearly in patient consent.

Can clinics still compound semaglutide after the FDA shortage ended?

Yes, when clinically justified for a specific patient. Patient-specific 503A compounding remains available for documented medical need, custom dosing, or allergen avoidance. Office-stock 503B has tighter restrictions.

What's the patient price difference between branded and compounded GLP-1?

Branded retail runs $1,000-1,400/month cash. Compounded programs typically retail $250-500/month and still produce 60%+ gross margin for the clinic.

Why are clinics moving to tirzepatide over semaglutide?

Higher average weight loss in trials, lower nausea reports in our network, and patient demand driven by Zepbound publicity. Most new programs offer both and let the provider choose.

Is compounded semaglutide the same molecule as Ozempic or Wegovy?

Compounded semaglutide uses the same active pharmaceutical ingredient. The differences are formulation, base (acetate vs sodium), excipients, and pharmacy source. Clinics should disclose this clearly in patient consent.

Can clinics still compound semaglutide after the FDA shortage ended?

Yes, when clinically justified for a specific patient. Patient-specific 503A compounding remains available for documented medical need, custom dosing, or allergen avoidance. Office-stock 503B has tighter restrictions.

What's the patient price difference between branded and compounded GLP-1?

Branded retail runs $1,000-1,400/month cash. Compounded programs typically retail $250-500/month and still produce 60%+ gross margin for the clinic.

Why are clinics moving to tirzepatide over semaglutide?

Higher average weight loss in trials, lower nausea reports in our network, and patient demand driven by Zepbound publicity. Most new programs offer both and let the provider choose.

What exactly does Direct Peptide Sales do?

We are a referral and introduction service. We verify your business and the states it serves, then introduce you to licensed telehealth prescribers and 503A or 503B pharmacies. You contract directly with them. We do not sell, price, prescribe, compound, bill, or ship any product.

How fast can my practice be introduced to a source?

Most qualified practices receive an introduction within one business day of applying. How quickly you go live after that depends on the agreement you sign with the prescriber and pharmacy you choose.

Nothing to apply, and we do not charge practices a fee. Product pricing, account terms, and any minimums are set by the pharmacy or prescriber you contract with, not by us.

Where do the peptides come from and are they verified?

Product comes from the licensed US 503A and 503B pharmacies you contract with. We only introduce sources that issue independent per-lot Certificates of Analysis covering identity, purity, sterility, and endotoxin. You can review sample COAs on this site before you apply.

Who handles prescribing, billing, and shipping?

The licensed prescriber and the pharmacy do. Prescribing is the provider's independent clinical decision, and dispensing, billing, and shipping sit with the pharmacy. We are not part of that transaction.

What if I'm not a licensed clinic?

Non-licensed wellness businesses such as coaches, gyms, studios, and nutrition practices can be introduced to a licensed telehealth prescriber who owns the clinical relationship. You never prescribe, hold, or dispense product.

How do you vet the sources you introduce?

Every source must be a named 503A pharmacy or FDA-registered 503B outsourcing facility, hold non-resident licensure in the states it ships into, issue per-lot Certificates of Analysis, and use prescribers licensed in the patient's state. We decline sources using research-use-only language.

Which states do you serve?

We make introductions across the United States and match you to partners that hold the right licensure for the states you serve.

GLP-1 comparison

Compounded vs branded GLP-1 for clinics

Patients ask about Ozempic, Wegovy, Mounjaro, and Zepbound. Clinics need to know when compounded semaglutide and tirzepatide make more sense, when they don't, and how to present the choice honestly.

Direct Peptide Sales is a referral service for licensed practices and wellness businesses. We introduce you to licensed prescribers and 503A/503B pharmacies. We do not sell, prescribe, bill, or ship product.

Last reviewed September 2, 2026 · Editorial policy

The molecule is the same. The economics aren't.

Branded GLP-1s are FDA-approved finished products with national marketing and insurance friction. Compounded GLP-1s use the same active ingredient through a licensed pharmacy at a fraction of the cash price. For uninsured or self-pay patients, compounded is often the only realistic path.

Branded Wegovy / Zepbound: $1,000-1,400/mo cash retail
Compounded semaglutide / tirzepatide: $250-500/mo retail
Clinic gross margin on compounded: typically 55-70%
Branded carries insurance complexity; compounded is straight cash-pay

When branded is the better answer

Some patients should be on the branded product. We help clinics build that filter into intake so the program stays defensible.

Insurance covers Wegovy or Zepbound with low copay
Patient has a contraindication that only the branded label addresses
Patient is risk-averse and wants the FDA-approved package

When compounded is the better answer

Most cash-pay weight-loss patients land here. Document the clinical rationale and informed consent the same way every time.

Patient is uninsured or has GLP-1 explicitly excluded
Patient needs micro-dose titration not available in the branded label
Patient has an excipient allergy
Documented shortage of the branded equivalent

Patient script: how to present the choice

The patients who churn fastest are the ones surprised later that they're on a compounded product. Disclose at intake, in writing, and verbally.

Name the molecule (semaglutide / tirzepatide), then the source (503A pharmacy)
Show the COA for the lot they're receiving
Confirm informed consent that compounded is not FDA-approved
Quote the all-in monthly price with no surprises

What Direct Peptide Sales provides

We support both. Most clinics in our network offer compounded as the default cash-pay program and refer out to branded when insurance covers it.

503A and 503B sourcing of semaglutide and tirzepatide
Independent COAs on every batch
Branded patient portal with consent and titration tracking
Monthly subscription billing with refill compliance

Frequently asked questions

Is compounded semaglutide the same molecule as Ozempic or Wegovy?: Compounded semaglutide uses the same active pharmaceutical ingredient. The differences are formulation, base (acetate vs sodium), excipients, and pharmacy source. Clinics should disclose this clearly in patient consent.
Can clinics still compound semaglutide after the FDA shortage ended?: Yes, when clinically justified for a specific patient. Patient-specific 503A compounding remains available for documented medical need, custom dosing, or allergen avoidance. Office-stock 503B has tighter restrictions.
What's the patient price difference between branded and compounded GLP-1?: Branded retail runs $1,000-1,400/month cash. Compounded programs typically retail $250-500/month and still produce 60%+ gross margin for the clinic.
Why are clinics moving to tirzepatide over semaglutide?: Higher average weight loss in trials, lower nausea reports in our network, and patient demand driven by Zepbound publicity. Most new programs offer both and let the provider choose.
What exactly does Direct Peptide Sales do?: We are a referral and introduction service. We verify your business and the states it serves, then introduce you to licensed telehealth prescribers and 503A or 503B pharmacies. You contract directly with them. We do not sell, price, prescribe, compound, bill, or ship any product.
How fast can my practice be introduced to a source?: Most qualified practices receive an introduction within one business day of applying. How quickly you go live after that depends on the agreement you sign with the prescriber and pharmacy you choose.
What does it cost?: Nothing to apply, and we do not charge practices a fee. Product pricing, account terms, and any minimums are set by the pharmacy or prescriber you contract with, not by us.
Where do the peptides come from and are they verified?: Product comes from the licensed US 503A and 503B pharmacies you contract with. We only introduce sources that issue independent per-lot Certificates of Analysis covering identity, purity, sterility, and endotoxin. You can review sample COAs on this site before you apply.
Who handles prescribing, billing, and shipping?: The licensed prescriber and the pharmacy do. Prescribing is the provider's independent clinical decision, and dispensing, billing, and shipping sit with the pharmacy. We are not part of that transaction.
What if I'm not a licensed clinic?: Non-licensed wellness businesses such as coaches, gyms, studios, and nutrition practices can be introduced to a licensed telehealth prescriber who owns the clinical relationship. You never prescribe, hold, or dispense product.
How do you vet the sources you introduce?: Every source must be a named 503A pharmacy or FDA-registered 503B outsourcing facility, hold non-resident licensure in the states it ships into, issue per-lot Certificates of Analysis, and use prescribers licensed in the patient's state. We decline sources using research-use-only language.
Which states do you serve?: We make introductions across the United States and match you to partners that hold the right licensure for the states you serve.

Launch your white-label peptide program with Direct Peptide Sales

Verified product, COAs, compliance, and patient subscriptions, all under your brand. Most practices onboard in under 30 days.

Get Started →